Prestige BioPharma (XKRX:950210) Marketable Securities : ₩80,542 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Prestige BioPharma Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Prestige BioPharma's Marketable Securities for the quarter that ended in Dec. 2024 was ₩80,542 Mil.

Prestige BioPharma's annual Marketable Securities increased from Jun. 2022 (₩34,619 Mil) to Jun. 2023 (₩176,390 Mil) but then declined from Jun. 2023 (₩176,390 Mil) to Jun. 2024 (₩9,381 Mil).

Prestige BioPharma Marketable Securities Historical Data

The historical data trend for Prestige BioPharma's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prestige BioPharma Marketable Securities Chart

Prestige BioPharma Annual Data

Trend

Jun20

Jun21

Jun22

Jun23

Jun24

Marketable Securities

2,422.78

377.68

34,619.07

176,390.48

9,381.30

Prestige BioPharma Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Marketable Securities	Get a 7-Day Free Trial															37,939.51	43,611.45	9,381.30	52,441.84	80,541.57

Prestige BioPharma Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Prestige BioPharma (XKRX:950210) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Prestige BioPharma Marketable Securities Related Terms

Thank you for viewing the detailed overview of Prestige BioPharma's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Prestige BioPharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prestige BioPharma Ltd (XKRX:950210) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

2 Science Park Drive No. 04-13/14, Ascent Tower B, Singapore Science Park, Singapore, SGP, 118222

Website

https://www.prestigebiopharma.com

Prestige BioPharma Ltd is a biopharmaceutical company. The company is focused on the development of biosimilars and new antibody therapeutics. It focuses on oncology and immune disorders, developing new and similar antibody drugs for solid tumor, pancreatic cancer, and arthritis.

Prestige BioPharma Headlines

No Headlines